Asan Medical Center: Lung Neoplasms trials
The registry lists 12 Lung Neoplasms studies with Asan Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 6Phase 3 1No phase 4(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Beneficial Effect of Pulmonary Rehabilitation in Lung Cancer Patients Receiving Radiation TherapyStatus unknownNCT05414188Not applicable
- Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping MutationStatus unknownNCT03693339Phase 2
- PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic AbnormalitiesStatus unknownNCT03693326Phase 2
- Dabrafenib and Trametinib in Patients With Non-small Cell Lung Cancer Harboring V600E BRAF MutationStatus unknownNCT03543306Phase 2
- Haploidentical NK Cells After Pemetrexed in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)CompletedNCT03366064Phase 1
- Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung CancerStatus unknownNCT01593293Phase 3
- First Line Gefitinib by FDG-PET Metabolic ResponseStatus unknownNCT01510990Phase 2
- Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung CancerCompletedNCT01196234Phase 2
- The Role of Narrow Band Imaging Videobronchoscopy in Lung CancerCompletedNCT01178190
- FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung CancerStatus unknownNCT01170923Phase 2
- The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung CancerStatus unknownNCT01000428
- Incidence of Postthoracotomy Pain Following General Anesthesia: A Comparison Between TIVA and Inhalation AnesthesiaStatus unknownNCT00935571